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Abstract
Context: The contribution of copper-bearing intrauterine devices (IUDs) to overall contraceptive protection has declined in many countries,
despite their well-known advantages. In response, initiatives to promote this method have been undertaken.
Objective: To review and interpret the experience of interventions to promote use of IUDs in low- and middle-income countries in order to
provide strategic guidance for policies and programs.
Methods:We conducted a systematic search of Medline, Popline, Embase and Global Health electronic databases for relevant journal papers,
reports and gray literature since 2010. Telephone interviews were held with two donors and six international family planning organizations.
Results: We identified a total of 31 publications. Four reported the results of randomized control trials and three were derived from quasi-
experiments. The majority were based on service statistics. Eight publications concerned interventions for HIV-positive women or couples,
nine for postpartum or postabortion cases and 14 for general populations. Intervention approaches included vouchers, franchising of private
practitioners, mobile outreach services, placement of dedicated staff in high-volume facilities and demand creation. Most publications
adduced evidence of a positive impact and some reported impressively large numbers of IUD insertions. Results to date on the uptake of
IUDs in postpartum interventions are modest. There is also almost no evidence of effects on IUD use at national levels. Implant uptake
generally exceeded IUD uptake when both were offered.
Conclusion: The evidence base is weak and offers few lessons on what strategies are most effective. The overall impression is that IUD use
can be increased in a variety of ways but that progress is hampered by persistent adverse perceptions by both providers and potential clients.
Provider enthusiasm is a key to success. The lack of a population impact stems in part from the fact that nearly all interventions are initiated
by international organizations, with limited national reach except in small countries, rather than by government agencies.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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1. Introduction
It is often stated (correctly but deceptively) that intrauterine
devices (IUDs) are worldwide the most commonly used
reversible contraceptivemethod. This fact is largely a reflection
of high use in China's vast population; this one country
accounts for over 60% of all IUD use [1]. China is not the only
country where this method dominates. Out of 159 countries
with recent national data, IUDs comprise 40% or more of all
modern method use in a further 15 [2]. However, IUD's share
of modern method mix is pitifully small, at less than 5%, in 63
countries and only 5%–9% in a further 32 countries. Most
countries with very low IUD use are in Africa. Moreover,
IUD's share is declining in many countries, in part because of
the growing prevalence of injectables [3].
These sharp disparities in use are not unique to IUDs but
reflect the fact that method mix is highly skewed in many
countries. Skewness is poorly understood. It is unrelated to
human development index, strength of family planning
programs or the overall prevalence of use [4]. We speculate
that an explanation has to be sought in the political history of
contraceptive provision and subsequent path dependency. In
the early years of family planning promotion, most govern-
ments had to focus efforts on one or two methods and, once a
method becomes established, it is increasingly favored by both
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staff and couples. The familiar becomes the desirable. The
imprint of early policy priorities is clearly seen in countries
with high IUD use, such as China, Vietnam and many
countries of the former Soviet Union.
Clearly, no ideal or target level of use can be set for IUDs.
Nevertheless, stubbornly low levels of use in many countries
and declines in many others are of concern because of the
established advantages of IUDs: high effectiveness, few
medical contraindications, low discontinuation, ease of use,
low cost and suitability for postpartum uptake. In response,
major initiatives have been made in the past 5 years or so to
revitalize the IUD agenda in low- and middle-income
countries, with financial backing from governments and
foundations and technical support from large international
organizations, notably Marie Stopes International (MSI) and
Population Services International (PSI).
Our purpose in this paper is to review the experience to date
and to distil the lessons learnt in order to inform future policies
and programs. Attention is restricted to copper-bearing IUDs.
The levonorgestrel intrauterine system (LNG IUS) has proved
to be a popular option in the United States and a few European
countries, and some commentators have urged its promulga-
tion in Africa, Asia and Latin America [5]. Falling product
prices favor this proposition, though cost is likely to remain a
concern for donors [6]. Potential advantages of LNG IUS also
include its role in treating menorrhagia and dysmenorrhea.
However, experience thus far in these poorer regions is too
sparse to merit consideration here.
2. Methods
This paper is based on subset of publications identified in a
wider systematic search of literature on IUDs published since
January 2010. This aimed to retrieve articles from peer-
reviewed journals and gray literature, relating to any country,
concerning facilitators and barriers to IUD use, users' and
providers' points of view, or describing interventions aimed at
increasing the uptake and continued use of the method.
We searched Medline, Popline, Embase and Global Health
electronic databases using keywords and subject headings. This
searchwas preceded by amanual search of four journals in order
to establish keywords that would capture the relevant literature.
A total of 102 potentially relevant papers were identified in
these four journals. Studies were limited to those involving
human subjects. No limitation was set on language, but search
terms were in English. The search terms were as follows: IUD
OR IUS OR LNG IUSOR “Copper T”OR “Multiload Cu375”
OR “Mirena” OR “intrauterine device” OR “intrauterine
system” OR “intrauterine contraception” OR “Levonorgestrel-
releasing intrauterine system.”Where possible, a limitation was
set on search terms being present in the title or abstract. Details
of the search are shown in Fig. 1.
As a supplement to the literature review and to assist with
interpretation of results, one of the authors conducted
semistructured telephone interviews with staff of the following
organizations: US Agency for International Development,
UK Department for International Development, MSI, PSI,
Pathfinder International, International Planned Parenthood
Federation, DKT International and FHI360. We identified an
initial list of organizations known to be active in IUDpromotion
and added additional ones by snowballing. Contact was made
initially to the most senior representative of each organization
who was asked to participate or identify an appropriate senior
staff member. All but one organization agreed to participate.
Interviewees were requested to represent the experience of their
institution. The purpose of the interviews was to identify the
scale of IUD promotion activities and main delivery and
demand-creation mechanisms, obtain a general evaluation of
difficulties and obstacles encountered, and obtain impressions
of IUD compared with implant acceptability. As many of these
organizations were responsible for the publications under
review, we considered their insights to be especially valuable.
We have drawn on this material in the discussion at the end of
the paper.
3. Results
We found a total of 31 papers and reports that documented
the results of interventions, projects or programs in terms of
IUD acceptance or use in Africa, Asia or Latin America. Some
projects were solely intended to promote IUDs, others gave an
equal emphasis to implants as the main alternative long-acting
reversible method (LARC) or to long-acting reversible and
permanent methods (LARPMs), while others promoted a wider
range of methods. Among these 31, 4 were randomized control
trials (RCTs), 4 were quasi-experiments, 5 were cohort studies
without controls, 1 was a before–after study without controls
and 1 was a Cochrane review. The remainder were based on
service data, either for a single period or in the form of a time
series: some compared outputs with independent sources. In
addition, we located eight short program briefing documents,
mainly from PSI. These briefs will not be reviewed here except
where they add significantly to the main body of literature.
The Cochrane review located nine interventions in which
copper-IUD uptake was explicitly mentioned as an outcome
[7]. All but one study were published before 2010 and thus
beyond the scope of this review but, in brief, the results
suggested that antenatal, postnatal and perinatal counseling
can improve uptake, but the limited evidence was negative
on the effect of home visits and postabortion counseling.
The remaining publications fall into three main categories
according to target population: HIV-related, postpartum and
postabortion, and the general population. Each is considered
below.
3.1. HIV-related initiatives
In the more recent literature, eight publications covering
seven studies, summarized in Table 1, reported on the effect of
interventions for HIV-positive women, concordant or discor-
dant couples [8–15]. All were facility based and involved
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counseling or exposure to informational videos, with an
emphasis on LARCs or solely on IUDs. The end point in some
studies was immediate method-specific uptake, while others
had a prospective dimension.
A cluster RCT that integrated family planning into AIDS
facilities demonstrated a considerable effect on contraceptive
uptake but a negligible impact on IUD use compared with
injectable or implant use [8]. An RCT in Zambia directed at
HIV-concordant and HIV-discordant couples found that
exposure to a video on LARCs was effective at raising use
[14]. Among couples using nomethod at baseline, 6% chose an
IUD, 14% an implant, 45% injectables and 33% oral
contraceptives. Among those already contracepting, 29%
switched, mainly to LARCs. The intervention had an effect
on subsequent pregnancy risk among prior users but not among
prior nonusers [15]. Similarly, an intervention to increase
LARC uptake in Lusaka and Kigali among HIV-discordant
couples had a much greater impact on implant than on IUD
uptake, with a threefold difference in both sites [11]. The
authors thought that provider bias may have been partly
responsible, because implants are simpler to insert than IUDs.
In Zimbabwe, a small quasi-experiment involving staff training
in LARC provision and interactive educational sessions also
had a large impact on implant use at 3months but little effect on
IUD uptake [13]. Women preferred implants because of the
shorter duration of use, no need for an immediate return visit
and the fact that the implant, unlike the IUD, is inserted
superficially and thus visible to the user [13]. Two projects with
particular emphases on IUDs, one in Malawi and the other in
Thailand, showed high uptake of this method among
HIV-positive women after counseling [9,12].
3.2. Postpartum and postabortion initiatives
Nine publications, summarized in Table 2, concerned
contraceptive counseling and provision following birth,
abortion or miscarriage [16–24]. A major effort to provide
postpartum IUD services in six countries, three in Asia and
three in Africa, involved 330 hospitals in India and 78 health
facilities (mainly hospitals) in the other countries. Major
investments in national advocacy, training, institutional
development and inculcation of local ownership were made.
Over a period ranging between countries from 3 years to
6 months, a total of 106,000 insertions were recorded
[22]. Among women counseled, the percentage who had an
insertion ranged from 2.3% in Pakistan to 5.8% in the
Philippines in the four countrieswhere record-keeping allowed
this calculation.
Fig. 1. Flowchart of literature search.
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In a project spanning eight West African countries, 18
providers from major teaching hospitals were trained in
postpartum IUD counseling and insertion. In three countries
with relevant data, about 7% of counseled women had a device
inserted [23]. Strikingly higher postpartum IUD acceptance was
reported in a small project involving training in IUDprovision to
staff in 11 Nigerian private health facilities. Of 728 women who
delivered during the study period, 41% had an insertion [18]. In
contrast, a small postpartum trial in South Africa had a very
modest effect on IUD use [10]. Briefing documents distil the
lessons from programs to increase postpartum IUD uptake
[25,26]. These lessons include the need to gain support of key
clinical leaders, to orient a broad range of staff beyond those
who will be actively involved in IUD counseling or insertion, to
ensure effective collaboration and communication between
antenatal, delivery and family planning staff, and to ensure the
continuous availability of trained IUDproviders. Such programs
are especially complex because of the need for collaboration
between staff with differing specialist duties. Projects are only
likely to be effective in high-volume settings where demand is
sufficient to allow trained providers to maintain skills.
Community actions can stimulate demand.
Table 1
HIV-related interventions
Author Population Design Intervention Results
Grossman et al. [8] Kenya Cluster-RCT. Baseline and endline
periods were compared, as well as
pregnancy rates during the follow-up
year.
18 public HIV clinics, 12 intervention
and 6 control. Intervention was
integration of FP services, including
LARCs, into HIV clinic; control was
referral of clients to FP clinic at the same
facility.
Women at integrated sites were
significantly more likely to use more
effective contraceptive methods at
endline, compared to controls. In
intervention facilities, IUD use rose
0.3%–1.0%, implants 0.6%–8.3%, and
injectables 13.3%–22.5%. No difference
was observed in incident pregnancy rates
between intervention and control.
Haddad et al. [9] Malawi Service data from one facility Detailed counseling on FP to 276 HIV+
women interested in FP and offer of
immediate IUD insertion
35% of counseled women chose IUD
but, regardless of initial choice, 79%
agreed to same day insertion
Hoke et al. [10] South Africa Pre- and post-test (2 samples of 265
postpartum PMTCT clients in 5 health
centres), intervention tracking tool,
and in-depth interviewswith providers
Service providers received training to
strengthen contraceptive counseling and
services, including IUDs, and referral for
sterilization.
At both pre- and post-intervention, 7%
of clients were sterilized and IUD use
was negligible; by comparison, 75% of
clients used injectables. Intervention
shortcomings and health system
constraints explained the failure to
produce intended effects.
Khu et al. [11] Rwanda and
Zambia
Cohort study of HIV discordant couples Participants enrolled in a longitudinal
cohort study of heterosexual transmission
who desired to delay fertility for
≥3 years were counseled on LARC
methods and offered an IUD or implant
on-site.
In Rwanda among participants, 89%
(N=365) were counseled on LARCs and
8% adopted IUD and 27% implant. In
Zambia, 67% (N=528) received LARC
counseling and 7% adopted IUD and
26% implant.
Landolt et al. [12] Thailand Cohort study of 66 HIV+ women Detailed counseling on IUDs (not on
other methods)
44% had an IUD inserted. Continuation
at 6 months was 93%.
Sarnquist et al. [13] Zimbabwe Quasi-experimental prospective trial Nurses at 4 facilities trained in LARC
provision. Intervention group (n=65
HIV+ women) received 3 group
sessions on FP etc., mainly at ANC.
Control group (n=33 HIV+ women)
received standard care. Prior LARC use
very low in both groups
At 3 months postpartum, IUD use was
1.6% vs. 9.1% (ns) and implant use was
86% vs. 73% (ns). Implants preferred
because of shorter duration, no need for
return visit and visibility of device
Stephenson et al. [14];
Wall et al. [15]
Zambia 4-armed RCT Sero-discordant or concordant-positive
couples were recruited, randomized and
then exposed to 1 of 4 video-based
interventions: (1) LARC-related; (2)
motivational; (3) both (4) neither
(control). Data on contraceptive choice
made straight after enrolment and
pregnancy rates over follow-up of
16 months evaluated.
21.5% were already using a method
other than condom, among these 29%
switched method, mostly to a
longer-term method. 78.4% were not
using any method or were using
condoms. 92% of these adopted a new
method, with a minority choosing IUD
(3%) or implant (12%). Exposure to
arms 1 and 3 resulted in significantly
lower pregnancy rate than arms 2 and 4
among those already using prior to
intervention but no effect on nonusers
at baseline.
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As part of a program to integrate postabortion care and
family planning in emergency settings in four African countries
and Pakistan, 52,600 new users were reached, of whom 45%
chose implants and 16% IUDs. The IUD share rose over time in
three countries following renewed emphasis on this method
[16]. A comprehensive program in Ethiopia trained and
mentored staff at 101 public-sector facilities in postabortion
LARC provision, improved logistical support and oriented
health extension workers. Over 4 years, acceptance of
contraception rose sharply and IUD insertions among acceptors
increased from close to 0 to 12%, though implants were much
more likely to be the method of choice [24]. An RCT in Brazil
reported no success with IUD promotion and only limited
impact was evident in Gabon [19,21].
3.3. Programs for general populations
A total of 14 publications reported on projects for the
general population [27–40]. The most common approach to
promote IUD use in the general population is the simple one
of training and supporting providers together with
demand-creation activities. Other strategies include voucher
schemes, social franchising of private-sector practitioners,
mobile outreach, integration with immunization services and
Table 2
Postpartum and postabortion interventions
Author Population Design Intervention Results
Curry and Ross [16];
Curry et al. 2015b [17]
Chad, DRC,
Djibouti, Mail
and Pakistan
Facility records (N=79),
July 2011–December 2013
Supporting Access to Family Planning
and Post-Abortion Care in Emergencies
(SAFPAC) initiative: Provider training,
improved supply chain management,
regular supervision, and community
mobilization, with focus on LARCs.
52,616 new users of modern
contraceptive methods recruited in 5
countries. Contraceptive acceptance
among PAC clients ranged from 28%
to 77%, of whom 45% chose implants
and 16% IUDs. In Chad, DRC and
Pakistan, IUDs increased share of
method mix, following renewed
emphasis on this method.
Eluwa et al. [18] Nigeria Service data,
May 2014–Feb 2015
11 private-sector providers from 11
facilities trained in postpartum IUD
services by MSI
Of 728 women delivered, 41% had
postpartum insertion.
Carneiro Gomes Ferreira
et al. [19]
Brazil RCT 30-min personalized face-to-face
contraceptive post-abortion counseling
vs. standard group counseling. N=123
women in each.
At 6 months, contraceptive use was
41% higher in the intervention group
but none chose IUD.
Huang et al. [20] China Single-intervention cohort of
postpartum migrant women
(N=840) and comparison
with 2 preintervention cohorts
from same facility
Free contraceptive counseling and a
choice of method offered prior to
discharge. Counseling and support were
offered at 1.5, 3, 6, 9 and 12 months
postpartum via telephone and/or clinic
visits.
The overall contraceptive prevalence at
12 months was higher than in
nonintervention cohorts: 97% vs. 74%
and 63%. Method mix in intervention
cohort was IUDs 40%, condoms 39%,
sterilization 8%, and DMPA 7%.
Mayi-Tsonga et al. [21] Gabon Single-intervention cohort of
women admitted to a single
facility for abortion
complications (N=383)
During admission, women received
counseling on the copper-bearing IUD
and other modern contraceptive methods.
Over 90% accepted to initiate a
contraceptive method. 9.3% chose a
LARC method.
Pfitzer et al. [22] Ethiopia, Guinea,
India, Pakistan,
Philippines and
Rwanda
Service data JHPIEGO and MCHIP integrated PPFP
and PPIUD services into maternal care in
high-volume facilities. National policies
and training materials introduced. A pool
of national trainerswas formed to support
program expansion and sustainability.
Number of women counseled ranged
from 1.7 million in India to 16,399 in
Ethiopia. Percentages of PPIUD
acceptors ranged from 2.3% of women
counseled in Pakistan to 5.8% in the
Philippines. The overarching lesson
from these programs is the importance
of engaging government leadership and
building local ownership.
Pleah et al. [23] Benin, Chad, Cote
d'Ivoire, Niger,
Senegal, Togo
Service data 2014–2015 18 providers from main teaching hospital
in each country trained in postpartum IUD
services, with support from JHPIEGO
Excluding Chad, 2269 IUD insertions
performed over 2 years. For 3 countries
with relevant data, about 7% of
counseled women accepted IUD.
Samuel et al. [24] Ethiopia Service data, 2010–2014 545 mid-level staff involved in
postabortion services in 101 public-
sector trained and supported by IPAS/
MoH with emphasis on LARCs. Demand
creation via health extension workers
Over 4 years, uptake of postabortion
contraception rose from 58% to 83%.
IUD's share rose from 0.1% to 12%;
implant rose from 2% to 43%.
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Table 3
General population interventions
Author Population Design Intervention Results
Khurram Azmat
et al. [27]
Pakistan Quasi-experimental design with 2
intervention and 2 control districts.
Baseline and endline surveys,
18 months apart, carried out in each
16 private sector female providers trained
under MSI social franchising scheme.
Fieldworkers provide FP counseling and
free IUD vouchers.
Modern method rose from 27% to 48% and
IUD use from 2% to 14% in intervention
areas. No change in control areas. Vouchers
accounted for 35% of IUD insertions.
Blumenthal
et al. [28]
13
developing
countries
Service data (2009–2010) on IUD
acceptors, compared with data on
IUD users from representative
national datasets
A 13-country PSI initiative focused on
increasing consumer demand and high-
quality IUD services. Services were
provided through (a) private sector-
franchised or affiliated clinics, (b) providers
seconded to the public sector and (c) outreach
clinics. Demand creation through special
“event” days and mass media
576,000 IUD and 106,501 implant insertions
performed in 2009–2010. Compared to
national IUD users, users in this program
were slightly younger and less educated.
Among IUD acceptors, 24% used no modern
method at the time of IUD initiation, and 28%
reported injectable use in the three previous
months.
Boddam-Whetham
et al. [29]
Yemen and
Pakistan
Service data, 2014, compared with
expected number on business-as-usual
assumption
Vouchers for LARPMs distributed,
redeemable at 113 private providers in
Pakistan under MSI franchise and an
unspecified number of mainly public sector
facilities in Yemen
In Yemen, 56,000 vouchers issued, of which
1135 were redeemed. In Pakistan, 84,000
vouchers issuedwith redemption rate of 88%.
IUD insertions increased to 6800 against a
business-as-usual expectation of 2300.
Implants rose to 3800 against an expectation
of 285. In both countries, sterilizations fell.
Cooley [30] Mali Service data, 2009–2011, interviews
with key stakeholders and document
review
Urban outreach model designed to integrate
immunization and subsidized LARC
services. Initially piloted in the private
sector. 149 providers from 73 public sector
facilities trained
Over 41,000 women received a LARC,
compared to the 5543 women estimated to
be using LARCs in 2006. In 2011, 17,000
implant and 2400 IUD insertions performed
Ikamari [31] Kenya Service data Ministry of Health program to reinvigorate
IUD use by: consensus-building activities for
a range of stakeholders; advocacy and
sensitisation activities among providers,
clients and the general public; capacity-
building and service-delivery activities; and
demand-creating activities
The number of new IUD users in the 97
facilities supported by the program increased
from151perquarter at baseline in early2003 to
373 per quarter in early 2005. The cumulative
number of IUD users in project sites over the
2-year intervention period was approximately
2800 women. The number of facilities that
could provide IUDs rose from 5% to 35%.
Keeley [32] Philippines Semistructured interviews and service
provision data
SHOPS Project involving private midwives
from two large midwife franchises. IUD
training provided
In 2012, data from 17 clinics showed that
IUDs accounted for 48% of all FP services.
Author concluded that private midwives
can provide IUDs on a viable basis and
serve the broader community.
Neukom et al. [33] Zambia Service data on women choosing
LARC, compared to national data
In a PSI project, 18 dedicated LARC
providers (all midwives) were placed in
high-volume public sector facilities for
14 months. Group talks given plus offer of
immediate service
In 14 months, 33,600 procedures performed
(66% implant and 34% IUD). Implied rate per
provider-day was about 8. The estimated
program costs, including the value of donated
commodities, averaged $13.0 per couple-year
of protection.
Muthamia
et al. [34]
Kenya
(Nairobi)
Cohort study of women (N=1334 at
endline; 50% attrition, 2011–2014),
surveys of facilities and staff
Comprehensive intervention coordinated by
JHPIEGO. LARC training and support for 92
public and private facilities.Multiple demand
creation activities
Over 4 years, use of any modern method
rose from 44% to 55%; IUDs, from 2.1%
to 4.3%; and implants, from 2.4% to 8.9%.
Rahman et al. [35] Bangladesh Before–after surveys of women and
staff in 7 intervention districts and 3
controls
Comprehensive intervention, including
training in LARCs and demand creation
No effect on LARC uptake
Rattan et al. [36] Chad, DRC Service data, 2011–2015 Public-sector providers trained and supported
in LARCs by CARE (N=21 in Chad, 19 in
DRC). Demand creation
Over about 4 years, 47,000 and 36,000
new users recruited in Chad and DRC,
respectively. In Chad, IUD's share rose from
2% to 14%, and that of implant fell from 89%
to 50%. In DRC, IUD's share rose from 7% to
41%, and that of implant fell from74%to42%.
Rosapep [37] Bangladesh Service statistics, 2012–2014 and
monitoring data for participating
facilities, plus semistructured
interviews with staff andmanagement
Under The Strengthening Health Outcomes
through the Private Sector (SHOPS) project,
LARPM. 38 urban for-profit facilities
received customized assistance for LARPM
training, plus demand generation, and
commodity supply.
Among 1041 clients, method mix was 44%
tubectomy, 30% IUDs, and 24% implants.
Overall volume was low and stagnant.
Facilities were judged unsuitable to market
LARPMs with the intensity needed to
significantly increase demand. Skill
retention could be a problem.
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placement of dedicated LARC providers in high-volume
public facilities. Two publications reported the results of
quasi-experimental designs. The majority relied on service
data alone, though some estimated population impact by
comparison with national data. Publications are summarized
in Table 3 and a selective commentary follows.
Two publications describe the results of MSI projects
involving vouchers. Khurram Azmat and colleagues[27]
reported on a quasi-experiment in Pakistan with two
interventions and two control areas. Social franchising with
a voucher scheme for IUDs was launched. After 18 months,
IUD use had increased from 2% to 14% in the intervention
sites, though vouchers were implicated in only about
one-third of insertions, while remaining unchanged in the
control sites. The second paper documents achievements
using a similar approach but with vouchers extending to
implants and sterilization as well as IUDs in Pakistan and
Yemen [29]. In Pakistan, 84,000 vouchers were issued, of
which a remarkably high 88% were redeemed, mainly for
IUDs. In Yemen, 56,000 vouchers were issued, of which
only 2% were redeemed, partly because of disruption to
services due to civil unrest.
Dedicated LARC providers appear to have been successful
in Zambia in a PSI private–public partnership. A total of 18
specially trained midwives were placed in high-volume
public-sector facilities, offering group talks and immediate
provision of IUDs and implants [33]. The results imply the
performance of about eight procedures per provider-day,
two-thirds implant and one-third IUD. In Mali, a larger-scale
PSI project involved the training of 149 public-sector
providers to integrate LARC and immunization services
[30]. Given the number of trained providers, the 2400 IUD
insertions in 2011 were small, though implant acceptors in the
same year were much more numerous (17,000). As part of
another large private–public collaboration in Ethiopia, this
time involving Pathfinder, providers in 738 facilities were
trained in IUD insertion [38]. Before-after analysis of records
in 40 facilities showed that IUD's share of method-acceptance
rose from less than 1% to 5.7%, implying three to four
insertions per facility-day at endline. However, the represen-
tativeness of the 40 selected facilities is uncertain.
A paper by Rattan et al.[36], concerning Chad and the
Democratic Republic of Congo (DRC), is of particular interest
because of shifts over time in method-specific acceptance.
Service data between 2011 and 2015were used to document the
outputs of a program, supported byCARE, to train public-sector
providers in LARC services, supplemented by community-
based demand generation. Implants initially dominated method
choice, accounting for 89% of new users in Chad and 74% in
DRC, with only small minorities accepting IUDs. Because of
this imbalance, efforts were made to reinvigorate IUD use,
including retraining, enhanced compensation to staff, provision
of antibiotics for sexually transmitted infection treatment and
community activities to dispel rumors. Over a 4-year period,
implant's share fell to 50% inChad and 42% inDRC,while that
of IUDs rose to 14% in Chad and 42% in DRC.
A 13-country PSI initiative to provide high-quality IUD
services through franchising, seconding dedicated providers
to public-sector facilities and outreach clinics yielded
576,000 IUD insertions in 2009–2010 [41]. Similarly
impressive large numbers are reported in an MSI technical
brief [42]. In 2010, two million procedures were performed
in 40 countries, about half of which were IUD insertions. In
20 countries of sub-Saharan Africa, 167,000 IUDs were
provided against an estimated 576,000 total number of IUD
users in these countries, suggesting that MSI is a major
provider of this method. A more recent MSI publication,
focused mainly on implants, reported that the organization
was responsible for 750,000 implant and 250,000 IUD
insertions in 2012 in Africa [43].
Table 3 (continued)
Author Population Design Intervention Results
Tilahun et al. [38] Ethiopia Service data (2011–2014) in 40
purposively selected facilities,
qualitative information and survey of
IUD clients
After scale-up, providers in 738 public-sector
facilities trained in IUD services. Demand-
creation through health extension workers
and mass media
Examination of 50,000 records before and
again 3 years after intervention showed
that IUD share of method mix rose from
0.4% to 5.7%. Data imply 3–4 insertions
per facility-day.
Vance and Bratt
[39]
Tanzania Service data Retrospective cost-analysis of the ongoing
service delivery phase of the Marie Stopes
Tanzania mobile outreach service, focused on
LARPMs. Expeditions of 6 out of 14 outreach
teams over 5 months were examined.
Overall method mix was minilaparotomy
(44%), IUDs (37%), and implants (20%).
Based on the average cost per LA/PM
acceptor ($22.37) and the average cost per
CYP ($4.28), authors note that cost-
effectiveness is higher when higher numbers
are served. They recommend community
mobilization for demand generation and
coordination between health facilities in the
selection of sites.
White and Corker
[40]
Guatemala,
Laos, Mali,
Uganda
Service data, 2013–2014 Comprehensive approach (policy, service
strengthening, supply chain, demand
creation). 417 public-sector facilities supported
IUD insertions rose from 23,000 in first year
to 79,000 in second year.
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In a rare example of a government-led initiative, a broad
program to reinvigorate IUD acceptance was launched in
Kenya. In 97 facilities supported by the program, the number
of new IUD users doubled over 2 years from 151 per quarter to
373 [31].
4. Discussion
The evidence base concerning IUD promotion is weak,
certainly too weak to reach any conclusions on the relative
effectiveness of different service delivery or demand-creation
strategies. Only seven of the publications reviewed used an
experimental or quasi-experimental approach and most of
these concerned services at HIV/AIDS clinics. The dearth of
experimental research is partly due to the multifaceted and
community-based nature of many IUD projects, whose impact
would have been extremely expensive and complex to assess
by rigorous methods. However, for more straightforward
facility-based interventions, RCTs and quasi-experiments are
more feasible and the dearth of such evaluations is to be
regretted. We call for donors to be more willing to sponsor
rigorous family planning research.
The majority of papers and reports rely on the presentation
of facility records, or service data, with no information about
verification procedures. Results should be interpreted with
caution, because of the ever-present danger that some staff,
under pressure from above to demonstrate high performance,
will exaggerate achievements. Even when taken as totally
valid, results presented simply in the form of gross numbers of
IUD insertions are difficult to interpret. Several publications
partially overcame this defect by comparing project outputs
with national estimates of actual, or expected, numbers of IUD
users or acceptors. Presentation of time trends can also be
convincing, particularly when very low baseline levels of
IUD or LARC acceptance change radically in the presence of
an intervention.
Despite the limitations of the evidence, it is clear that IUD
uptake has been raised by different strategies, including
franchising of private providers, vouchers, placement of
dedicated staff in high-volume public facilities, mobile
outreach teams and so on. Clearly, a demand for IUDs exists
when appropriate promotional efforts are made. While the
numbers of IUD insertions reported in some publications are
impressively large, there is little sign of an impact at national
levels. Demographic and Health Surveys (DHSs) provide no
evidence of increasing IUD use in sub-Saharan Africa. Recent
surveys indicate that less than 1.4% of married women are
current IUD users, with the single exception of Kenya. It is
surely no coincidence that Kenya was the only country in the
region where we identified that government agencies initiated
IUD promotion. Similarly, the preliminary state-level results
of India's 2015–2016 National Family Health Survey and
Pakistan's 2012–2013 DHS indicate stagnant levels of IUD
use. One possible explanation is lack of government
commitment to the training, logistics and community education
needed for successful IUD promotion. The IUD agenda has
been driven largely by international NGOs which, despite
partnerships with the public sector, cannot be fully adequate
substitutes for the lack of nation-wide mobilization led by
government agencies.
As noted earlier, one of the key advantages of the IUD is
its suitability for initiation of use before discharge from
hospital after childbirth, a particularly important attribute in
view of the renewed international interest in strengthening
postpartum family planning. Evidence to date on the
effectiveness of introducing postpartum IUD services is
thin. We located only one large-scale, multicountry project
[22]. Taking into account the investment made in national
advocacy, imparting of local ownership, training and
institutional support, the results of this project appear to be
rather modest and implying a high cost–benefit ratio, with
IUD acceptance among counseled women ranging from 2%
to 6%. This is a priority area for future research.
One clear-cut conclusion from the review is that implant
uptake typically eclipses IUD uptake in projects that ostensibly
give equal emphasis to both. Several reasons for the relatively
low uptake of IUDs were advanced in the telephone
interviews. The most commonly mentioned factor concerned
provider biases and misconceptions. Providers prefer to
recommend methods that take less time and effort than
IUDs. Secondly, there is resistance from women who do not
feel comfortable having an insertion by a man, reinforced by
the fact that many facilities lack the space for privacy. Some
believe that IUDs are less effective than, for instance, oral
contraceptives. Side effects, in particular heavy menstrual
bleeding, act as a further deterrent. A third reason was lack of
promotion at the national level. The example of top-down IUD
promotion in China was cited. Though this policy initially
restricted choice, IUDs remain widely used and popular, even
more recently when a wider range of methods is available.
Additional reasons mentioned by more than one informant
included the difficulty of retaining provider skills and
confidence, particularly in rural areas where client load is
low, supply chain problems and restrictions in some countries
prohibiting nurses and midwives from inserting IUDs.
Several informants accepted that implants were easier to
promote than IUDs and are favored by some agencies for this
reason.Again, both provider and client factors were implicated.
Providers tend to favor implants because insertion is less
complex than for IUDs. The fact that implants are considerably
more difficult to remove than IUDs is not explained to women.
For women, implants were less intrusive than IUDs and, being
a relatively new method, have attracted less misconceptions
and concerns.
Among the remedies suggested by stakeholders were
information and education activities to countermisconceptions,
training and retraining of staff, retention of trained providers,
task shifting, and recruitment of enthusiastic, dedicated IUD
providers. One informant thought that addressing the lack
of incentives for staff to provide time-consuming and
skill-demanding IUD services was important. The example of
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a voucher scheme was mentioned. Initially, providers were
reimbursed more generously for implants than IUDs, simply
because the implant was a more expensive product. Unsur-
prisingly, implants were heavily favored by providers. When
reimbursement for IUDswas raised, this method becamemore
frequently used. This view is supported by the projects in Chad
and DRC where IUD uptake increased substantially after a
number of changes in service delivery were made including
enhanced compensation to staff for IUD insertions [35]. One
other project succeeded in increasing acceptance of IUDs
relative to implants partly by re-enthusing providers [15].
A prevailing impression from the literature and telephone
interviews with stakeholders is that effective IUD promotion is
certainly possible but is rather an uphill battle. It is rarely easy to
changemethodmix once the dominance of one or twomethods
has been established, except by the introduction of a totally new
method. The forces of familiarity are strong. Perhaps the key to
success for IUDs is provider motivation, as mentioned above.
In intensively supervised projects, it may be feasible to
reorientate staff toward greater enthusiasm for IUDs. Success
is reported in two projects reviewed here, though both also
engaged in extensive community-based efforts to dispel
adverse rumors [16,36]. In less intensive programs, it is more
difficult to generate the motivation for providers to actively
promote a procedure that is more demanding than alternatives,
except through the contentious and potentially corrupting use of
financial incentives. An alternative is the training of dedicated
IUD providers and placement in high-volume facilities, where
other methods are routinely available.
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